Carondelet St. Joseph’s Hospital First in Tucson to Offer Minimally Invasive Procedure for Patients Suffering from Painful Bone TumorsFeb 9, 2018
TUCSON, AZ – Feb 9, 2018 – Carondelet St. Joseph’s Hospital is the first hospital in Tucson to use a new technique to treat patients with painful bone metastases. The OsteoCool™ System is a cooled radiofrequency (RF) ablation technology that uses targeted heat to the tumor to intentionally dry out and kill cancerous cells.
“This medical innovation is another example of how we are providing some of the latest advances for the community,” said St. Joseph’s Hospital CEO Mark Benz. “Expanding access to care and providing some of the latest advancements is a commitment we make to this community and the patients we serve.”
Sometimes, when a patient has advanced cancer, it spreads to the spine, causing painful tumors. Metastatic bone disease has been reported to occur in 60-80% of cancer patients, most frequently among patients with primary malignancies of the breast, prostate, liver, and lung. Bone is the third most common location to where cancerous cells metastasize. But this new procedure can remove the spinal tumors and the pain that comes with it.
This technology allows physicians to destroy cancerous cells with just the right amount of heat. Through controlled temperature, the physician can deliver precise treatment to the location of the tumor. This minimally invasive procedure requires only local or moderate sedation and typically takes only 30 to 45 minutes. In most cases, patients go home the same day.
For information about how the procedure works or to discuss if this might be an appropriate treatment, patients can contact Carondelet St. Joseph’s Hospital by calling 844-366-9806 or visiting Carondelet.org.
This innovative therapy is intended for palliative treatment in spinal procedures by ablation of metastatic malignant lesions in a vertebral body and coagulation and ablation of tissue in bone during surgical procedures including palliation of pain associated with metastatic lesions involving bone in patients who have failed or are not candidates for standard therapy. For patients with tumors located in the cervical spine or who have a heart pacemaker or other electronic implant, this may not be the right procedural option.